The global market for Compounding Pharmacy was estimated at US$14.5 Billion in 2023 and is projected to reach US$19.7 Billion by 2030, growing at a CAGR of 4.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
How Are Compounding Pharmacies Tailoring Personalized Medicine for Modern Healthcare?
Compounding pharmacies play a critical role in modern healthcare by providing customized medications tailored to the specific needs of individual patients. Unlike mass-produced pharmaceuticals, compounded medications are created by pharmacists who mix ingredients to form personalized treatments, adjusting dosage forms, strengths, or ingredients based on a patient's unique requirements. This is particularly important for patients who cannot take commercially available medications due to allergies, difficulty swallowing pills, or specific dosage needs that are not available in mass-produced drugs. Compounded medications are used across a wide range of medical fields, including dermatology, pediatrics, pain management, and hormone replacement therapy. In recent years, the demand for personalized medicine has increased, as patients and healthcare providers seek more precise treatments that cater to individual health conditions. This shift highlights the growing importance of compounding pharmacies in filling the gaps left by standard pharmaceutical manufacturing, offering a personalized approach to medicine that enhances patient care and outcomes.
How Are Technological Advances Revolutionizing Compounding Pharmacy Practices?
The practice of compounding pharmacy has seen significant advancements, driven by cutting-edge technologies that have made the preparation of customized medications more efficient, accurate, and safe. Automation has been one of the most transformative developments, with automated compounding systems allowing for precise measurements of active ingredients, reducing human error, and increasing the speed of production. This is especially crucial in the preparation of sterile compounds, where any contamination can pose significant risks. Furthermore, advancements in pharmaceutical software have enabled compounding pharmacists to streamline their workflows, ensuring more accurate record-keeping, better inventory management, and compliance with regulatory standards. Digital platforms now allow pharmacists to cross-reference drug interactions and patient allergies quickly, further enhancing the safety and efficacy of compounded medications. The use of advanced compounding techniques, such as transdermal gels, rapid-dissolve tablets, and sustained-release formulations, has expanded the range of treatments available to patients, offering more flexible and innovative ways to deliver medications. Additionally, the rise of 3D printing technology in pharmaceuticals is beginning to influence compounding practices, with the potential to print personalized medications in precise dosages and forms, further pushing the boundaries of what can be achieved in tailored treatments. These technological innovations are improving the quality and accessibility of compounded medications, making personalized treatments more scalable and reliable.
How Is Compounding Pharmacy Serving Diverse Healthcare Needs Across Various Fields?
Compounding pharmacies cater to a diverse range of healthcare needs, providing solutions in areas where traditional pharmaceutical products may fall short. In pediatrics, for instance, compounded medications offer tailored dosages that are often unavailable in mass-market drugs, and pharmacists can prepare formulations in liquid, flavored, or chewable forms to make them more palatable for children. In dermatology, compounding pharmacies produce customized creams, ointments, and gels that address specific skin conditions such as psoriasis, eczema, and acne, often blending multiple active ingredients to create a comprehensive treatment in a single product. Pain management is another field where compounding pharmacies are vital, especially for patients with chronic pain who require precise formulations of medications such as opioids, muscle relaxants, or anti-inflammatories in customized doses or delivery methods, such as topical creams or transdermal patches, to minimize systemic side effects. Hormone replacement therapy (HRT) is another area where compounding pharmacies excel, creating individualized doses of bioidentical hormones tailored to the hormonal needs of patients undergoing menopause or other endocrine imbalances. Furthermore, compounding pharmacies are often relied upon in veterinary medicine, where medications for animals must be tailored in terms of dosage and formulation, sometimes flavored to ensure compliance. Across these various fields, compounding pharmacies offer personalized solutions that meet the specific needs of patients who might otherwise struggle to find appropriate treatments through conventional pharmaceuticals.
What Are the Factors Behind the Growth of the Compounding Pharmacy Market?
The growth in the compounding pharmacy market is driven by several factors, reflecting both the evolving needs of healthcare and advancements in pharmaceutical practices. One of the key drivers is the increasing demand for personalized medicine, as patients and healthcare providers seek more individualized treatments tailored to specific conditions, allergies, and preferences. This trend is particularly strong in fields like hormone replacement therapy (HRT), pain management, and pediatric care, where standard dosages and formulations often do not meet patient needs. Another significant factor is the shortage or discontinuation of certain medications from large pharmaceutical manufacturers, which has led healthcare providers to turn to compounding pharmacies to fill the gaps and ensure continued treatment for their patients. Additionally, regulatory changes and concerns about the safety and effectiveness of mass-produced medications, particularly with recalls or drug shortages, have spurred greater reliance on compounding pharmacies to provide alternative solutions. Technological advancements, such as the introduction of automation in compounding processes and enhanced digital tools for managing patient data, are also driving market growth by increasing the efficiency and accuracy of compounded drug production. Furthermore, the rise in healthcare costs and the growing number of aging populations in developed regions are pushing demand for more tailored and affordable treatment options, which compounding pharmacies are uniquely positioned to provide. Lastly, the increasing awareness of compounding's role in veterinary medicine, offering solutions that are often not available in the traditional pharmaceutical market, is expanding the scope of the compounding pharmacy market. Together, these factors are contributing to the sustained growth of compounding pharmacies as a critical element of personalized healthcare solutions.
Key Insights:
Market Growth: Understand the significant growth trajectory of the Oral Compounded Medications segment, which is expected to reach US$8.6 Billion by 2030 with a CAGR of a 5.2%. The Topical Compounded Medications segment is also set to grow at 4.3% CAGR over the analysis period.
Regional Analysis: Gain insights into the U.S. market, which was valued at $3.9 Billion in 2023, and China, forecasted to grow at an impressive 4.2% CAGR to reach $3.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
Detailed Market Analysis: Access a thorough analysis of the Global Compounding Pharmacy Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Compounding Pharmacy Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
How is the Global Compounding Pharmacy Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?
Report Features:
Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as B. Braun Melsungen AG, Dougherty's Pharmacy, Inc., Fagron NV, and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 27 Featured):
B. Braun Melsungen AG
Dougherty's Pharmacy, Inc.
Fagron NV
Fresenius Kabi AG
Village Compounding Pharmacy
Wedgewood Pharmacy
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Global Economic Update
Compounding Pharmacy - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Incidence of Chronic Diseases Expands Addressable Market for Customized Compounded Medications
Increasing Demand for Personalized Medicine Propels Growth of Compounding Pharmacies
Advancements in Pharmaceutical Compounding Strengthen the Business Case for Precision Dosage Solutions
Growing Focus on Pediatric and Geriatric Care Spurs Demand for Tailored Compounded Medications
Shortages of Commercially Available Drugs Throw the Spotlight on Compounding Pharmacies for Alternative Solutions
Rising Demand for Hormone Replacement Therapy (HRT) Accelerates Growth of Compounded Pharmacy Services
Emerging Need for Allergen-Free and Preservative-Free Medications Expands Opportunities for Compounding Pharmacies
Surge in Demand for Bio-Identical Hormones and Custom Pain Management Solutions Strengthens Business Case for Compounding
Rising Focus on Niche Therapies, Including Dermatology and Ophthalmology, Expands Market for Specialty Compounded Medications
Technological Innovations in Sterile Compounding Propel Growth of Safe and Efficient Compounded Medication Services
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Compounding Pharmacy Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
Table 2: World Recent Past, Current & Future Analysis for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 3: World Historic Review for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 4: World 16-Year Perspective for Compounding Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
Table 5: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 6: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 7: World 16-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 8: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 9: World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 10: World 16-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 11: World Recent Past, Current & Future Analysis for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 12: World Historic Review for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 13: World 16-Year Perspective for Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 14: World Recent Past, Current & Future Analysis for Nasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 15: World Historic Review for Nasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 16: World 16-Year Perspective for Nasal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 17: World Recent Past, Current & Future Analysis for Rectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 18: World Historic Review for Rectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 19: World 16-Year Perspective for Rectal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 20: World Recent Past, Current & Future Analysis for Ophthalmic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 21: World Historic Review for Ophthalmic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 22: World 16-Year Perspective for Ophthalmic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 23: World Recent Past, Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 24: World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 25: World 16-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 26: World Recent Past, Current & Future Analysis for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 27: World Historic Review for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 28: World 16-Year Perspective for Hospital Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 29: World Recent Past, Current & Future Analysis for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 30: World Historic Review for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 31: World 16-Year Perspective for Compounding Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 32: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 33: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 34: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
Table 35: USA Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 36: USA Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 37: USA 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
Table 38: USA Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 39: USA Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 40: USA 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
CANADA
Table 41: Canada Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 42: Canada Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 43: Canada 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
Table 44: Canada Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 45: Canada Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 46: Canada 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
JAPAN
Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
Table 47: Japan Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 48: Japan Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 49: Japan 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
Table 50: Japan Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 51: Japan Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 52: Japan 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
CHINA
Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
Table 53: China Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 54: China Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 55: China 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
Table 56: China Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 57: China Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 58: China 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
EUROPE
Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
Table 59: Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 60: Europe Historic Review for Compounding Pharmacy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 61: Europe 16-Year Perspective for Compounding Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
Table 62: Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 63: Europe Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 64: Europe 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
Table 65: Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 66: Europe Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 67: Europe 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
FRANCE
Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
Table 68: France Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 69: France Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 70: France 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
Table 71: France Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 72: France Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 73: France 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
GERMANY
Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
Table 74: Germany Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 75: Germany Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 76: Germany 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
Table 77: Germany Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 78: Germany Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 79: Germany 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
ITALY
Table 80: Italy Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 81: Italy Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 82: Italy 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
Table 83: Italy Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 84: Italy Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 85: Italy 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
UNITED KINGDOM
Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
Table 86: UK Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 87: UK Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 88: UK 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
Table 89: UK Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 90: UK Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 91: UK 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
REST OF EUROPE
Table 92: Rest of Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 93: Rest of Europe Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 94: Rest of Europe 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
Table 95: Rest of Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 96: Rest of Europe Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 97: Rest of Europe 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 99: Asia-Pacific Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 100: Asia-Pacific 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 102: Asia-Pacific Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 103: Asia-Pacific 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
REST OF WORLD
Table 104: Rest of World Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 105: Rest of World Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 106: Rest of World 16-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2014, 2024 & 2030
Table 107: Rest of World Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 108: Rest of World Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 109: Rest of World 16-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2014, 2024 & 2030
Compounding Pharmacies are a subset of Drugstores and Pharmacies that specialize in the preparation of customized medications. Compounding Pharmacies are able to create medications tailored to the specific needs of a patient, such as altering the dosage form, strength, or flavor of a medication. Compounding Pharmacies also offer medications that are not commercially available, such as those that are no longer manufactured or those that are not available in the desired dosage form. Compounding Pharmacies are regulated by the United States Pharmacopeia and the Food and Drug Administration.
Compounding Pharmacies are often used by patients who have difficulty taking commercially available medications, such as those with allergies or sensitivities to certain ingredients. Compounding Pharmacies also provide medications for veterinary use, such as medications for animals that are not available commercially.
Some companies in the Compounding Pharmacies market include Apothecary By Design, B&B Pharmaceuticals, and Wedgewood Pharmacy. Show Less Read more
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a 1-10 user license, allowing up to ten users have access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF.